| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 02/16/2005 | EP1244617B1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | EP1021184B1 Use of flunarizine for the topical treatment of ocular hypertension |
| 02/16/2005 | CN1582149A Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855830 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855174 Couplers for use in oxidative hair dyeing |
| 02/10/2005 | WO2005012274A1 Process for the preparation of 11-(1-piperazinyl)dibenzo `b, f! `1 ,4!-thiazepine, an intermediate in the synthesis of the antipsychotic drug quetiapine |
| 02/10/2005 | WO2005012266A1 (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
| 02/10/2005 | WO2005012249A2 Adamantyglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | WO2004060305A3 Anti-cancer medicaments |
| 02/10/2005 | US20050033005 Sulfonamide anions as catalysts for NCO oligomerization |
| 02/10/2005 | US20050032845 1,1-and 1,2-disubstituted cyclopropane compounds |
| 02/10/2005 | US20050032827 Sigma ligands for neuronal regeneration and functional recovery |
| 02/10/2005 | US20050032822 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections |
| 02/10/2005 | US20050032796 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/09/2005 | EP1505057A1 Method of purifying quaternary alkylammonium salt and quaternary alkylammonium salt |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1453816A4 Phenoxy amine compounds and compositions for delivering active agents |
| 02/09/2005 | EP1313560A4 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION |
| 02/09/2005 | CN1578760A Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188415C Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5)for treatment of sexual dysfunction |
| 02/09/2005 | CN1188405C New Morpholinobenzamide salts |
| 02/09/2005 | CN1188389C Benzamide derivatives for the treatment of diseases caused by cytokines |
| 02/08/2005 | US6852723 Aralkyl substituted piperazine compounds |
| 02/08/2005 | US6852718 Selective 5-HT2A antagonists useful in treatment or prevention of CNS conditions |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | US20050026953 Alkaloid that inhibits biosynthesis of mycotoxins and method for screening for mycotoxin inhibitors |
| 02/03/2005 | US20050026931 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 02/03/2005 | US20050026926 N, N'-disubstituted piperazine compounds and their use as analgesics |
| 02/03/2005 | US20050026907 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050025992 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1502576A2 Composition containing a 2-thioacetamide and use thereof for stimulating growth or preventing fall out of keratin fibres |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1330233B1 Method of treating stroke |
| 02/02/2005 | EP1165534B1 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575169A Mch antagonists for the treatment of obesity |
| 02/02/2005 | CN1187338C 5-phenyl-pyrimidine derivatives |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 02/01/2005 | CA2362698C Resorcinol derivatives |
| 02/01/2005 | CA2276719C Anilide derivatives and antiarrhythmic agents containing the same |
| 01/27/2005 | WO2005007637A1 Piperazine-based sensitisers |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007076A2 Colchicine derivatives |
| 01/27/2005 | WO2004108673A3 Inhibitors of papilloma virus |
| 01/27/2005 | WO2004087654A3 Phospholipase c inhibitors for use in treating inflammatory disorders |
| 01/27/2005 | WO2004069794B1 New arylpiperazinyl compounds |
| 01/27/2005 | US20050020838 Acetylenic compound useful in treating inflammatory disorders |
| 01/27/2005 | US20050020691 Pharmaceutical preparations comprising substituted beta-aminoalcohols |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020648 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 01/27/2005 | US20050020608 Antiallergens; solvent extraction |
| 01/27/2005 | US20050020576 Opioid antagonist; analgesics; antiinflammatory agents; side effect reduction |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 01/27/2005 | US20050020483 Sigma ligands for neuronal regeneration and functional recovery |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | CA2521990A1 Colchicine derivatives |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1499319A1 Bicyclo 4.4.0 antiviral derivatives |
| 01/26/2005 | EP1082303B1 Heterocyclic derivatives which inhibit factor xa |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571769A Process for the preparation of repaglinide |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1571665A Substituted N-phenyl 2-hydroxy-2-methyl-3, 3, 3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 01/26/2005 | CN1569845A Process for preparation of aripiprazole |
| 01/26/2005 | CN1569328A Synthesis of 1, 4-oxygen nitrogen heterocyclic hexane catalyst by ammonification of diethylene glycol and process thereof |
| 01/26/2005 | CN1569327A Preparation of 1, 4-oxygen nitrogen heterocyclic hexane catalyst by ammonification of diethylene glycol and process thereof |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846953 Treating central nervous system disorders such as pain, depression, anxiety, schizophrenia, Huntington's disease, Alzheimer's disease or amyotrophic lateral sclerosis |
| 01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 01/25/2005 | US6846925 Colchinol derivatives as angiogenesis inhibitors |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 01/25/2005 | CA2179377C Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 01/20/2005 | WO2005005394A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | WO2005005387A1 Sulfonamide derivatives as 5ht7 receptor antagonists |